Compare Burjeel Holdings Plc with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
AED 5,934 Million (Small Cap)
13.00
NA
0.00%
0.82
21.15%
2.76
Revenue and Profits:
Net Sales:
1,455 Million
(Quarterly Results - Jun 2026)
Net Profit:
146 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.72%
0%
-11.72%
6 Months
-38.76%
0%
-38.76%
1 Year
-54.45%
0%
-54.45%
2 Years
-43.86%
0%
-43.86%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Burjeel Holdings Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
460.91%
EBIT Growth (5y)
267.93%
EBIT to Interest (avg)
3.24
Debt to EBITDA (avg)
1.08
Net Debt to Equity (avg)
0.65
Sales to Capital Employed (avg)
1.52
Tax Ratio
7.19%
Dividend Payout Ratio
21.91%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8,410.03%
ROE (avg)
7,506.84%
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
2.76
EV to EBIT
11.43
EV to EBITDA
7.25
EV to Capital Employed
1.97
EV to Sales
1.39
PEG Ratio
0.23
Dividend Yield
NA
ROCE (Latest)
17.24%
ROE (Latest)
21.15%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
1,455.20
1,402.60
3.75%
Operating Profit (PBDIT) excl Other Income
320.50
234.00
36.97%
Interest
33.90
44.90
-24.50%
Exceptional Items
-24.90
71.80
-134.68%
Consolidate Net Profit
145.60
147.70
-1.42%
Operating Profit Margin (Excl OI)
152.90%
96.00%
5.69%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 3.75% vs 18.70% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is -1.42% vs 128.99% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
5,486.50
5,010.10
9.51%
Operating Profit (PBDIT) excl Other Income
1,030.60
897.00
14.89%
Interest
170.50
155.30
9.79%
Exceptional Items
73.00
2.10
3,376.19%
Consolidate Net Profit
502.60
360.30
39.49%
Operating Profit Margin (Excl OI)
117.60%
107.20%
1.04%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 9.51% vs 10.48% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 39.49% vs -33.33% in Dec 2024
About Burjeel Holdings Plc 
Burjeel Holdings Plc
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






